371 results on '"Broncel, Marlena"'
Search Results
2. The protective effects of empagliflozin on DNA oxidative changes in a model of vascular endothelial and smooth muscle cells damaged by oxidized cholesterol
3. When the same treatment has different response: The role of pharmacogenomics in statin therapy
4. Interleukin-33/sST2: Dynamic assessment in patients with acute coronary syndrome
5. The effect of maltose modified fourth generation poly(propylene imine) (PPI G4) dendrimers on the barrier functions and inflammatory activation of human vascular endothelium – Possible consequences for the medical application
6. Searching for serum biomarkers linking coronary heart disease and Helicobacter pylori infection using infrared spectroscopy and artificial neural networks
7. OxLDL as a prognostic biomarker of plaque instability in patients qualified for carotid endarterectomy.
8. Standards of Care in Diabetes. The position of Diabetes Poland – 2024
9. 2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.
10. Diabetes Mellitus
11. New possible pharmacological targets for statins and ezetimibe
12. Mitral valve prolapse—arrhythmic faces of the valve disease
13. The protective effects of PCSK9 inhibitors on DNA damage in peripheral blood mononuclear cells in familial hypercholesterolemic patients
14. Empagliflozin prevents human aortic smooth muscle cells damage induced by cholesterol
15. Lipoprotein(a) levels may temporarily increase during COVID-19: a pilot study.
16. Wytyczne Polskiego Towarzystwa Diagnostyki Laboratoryjnej i Polskiego Towarzystwa Lipidologicznego dotyczące diagnostyki laboratoryjnej zaburzeń gospodarki lipidowej. 2024.
17. Diabetes Mellitus
18. Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease
19. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
20. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
21. Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease
22. The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells
23. SGLT2 Inhibitors May Restore Endothelial Barrier Interrupted by 25-Hydroxycholesterol
24. The effect of statins intake on sleep quality
25. Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine
26. Intensive statin therapy, used alone or in combination with ezetimibe, improves homocysteine level and lipid peroxidation to a similar degree in patients with coronary artery diseases
27. IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms
28. Sulfenamide and Sulfonamide Derivatives of Metformin – A New Option to Improve Endothelial Function and Plasma Haemostasis
29. The effect of melatonin on the barrier properties of human primary aortic endothelial and human aortic smooth muscle cells based on the real-time cell electric impedance sensing system.
30. The effect of interleukin-35 on the integrity, ICAM-1 expression and apoptosis of human aortic smooth muscle cells
31. Studies towards biocompatibility of PAMAM dendrimers – Overall hemostasis potential and integrity of the human aortic endothelial barrier
32. BCG and SARS-CoV-2—What Have We Learned?
33. The relationship between COVID-19 severity, markers of endothelial impairment and Simple Covid Risk Index
34. The effect of oxidized cholesterol on barrier functions and IL-10 mRNA expression in human intestinal epithelium co-cultured with dendritic cells in the transwell system
35. The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults.
36. Expression of anti and pro‐inflammatory genes in human endothelial cells activated by 25‐hydroxycholesterol: A comparison of rivaroxaban and dabigatran
37. Elevated Lp(a) and course of COVID-19: Is there a relationship?
38. Euthyroid Sick Syndrome as a Prognostic Indicator of COVID-19 Pulmonary Involvement, Associated With Poorer Disease Prognosis and Increased Mortality
39. Antibodies towards TVLLPVIFF Amino Acid Sequence of TNF Receptor Induced by Helicobacter pylori in Patients with Coronary Heart Disease
40. The new ESC guidelines for the prevention of cardiovascular diseases – what changes do they bring to medical practice?
41. Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.
42. Dabigatran: its protective effect against endothelial cell damage by oxysterol
43. Extract of Aronia melanocarpa-modified hemostasis: in vitro studies
44. Neuroprotective Effect of SGLT2 Inhibitors
45. Relationship between COVID-19 severity, markers of endothelial impairment, and Simple Covid Risk Index.
46. Increased oxidative stress and decreased membrane fluidity in erythrocytes of CAD patients
47. The effect of 7-ketocholesterol and 25-hydroxycholesterol on the integrity of the human aortic endothelial and intestinal epithelial barriers
48. Severe hypodysfibrinogenemia in a young patient with pulmonary thromboembolism: a case report
49. A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol
50. Rivaroxaban protects from the oxysterol-induced damage and inflammatory activation of the vascular endothelium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.